WESTPAC BANKING CORP - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 176 filers reported holding ASCENDIS PHARMA A/S in Q4 2020. The put-call ratio across all filers is 1.39 and the average weighting 0.5%.

Quarter-by-quarter ownership
WESTPAC BANKING CORP ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q1 2023$2,908,664
-35.2%
27,128
-26.2%
0.04%
-40.9%
Q4 2022$4,487,300
-99.9%
36,742
-55.0%
0.07%
-48.4%
Q3 2022$8,426,015,000
+11.6%
81,600
+0.5%
0.13%
+30.6%
Q2 2022$7,551,141,000
-17.9%
81,230
+3.6%
0.10%
-7.5%
Q1 2022$9,200,553,000
-14.9%
78,396
-2.4%
0.11%
-5.4%
Q4 2021$10,807,065,000
-21.2%
80,332
-6.7%
0.11%
-23.8%
Q3 2021$13,722,681,000
+42.0%
86,095
+17.2%
0.15%
+51.5%
Q2 2021$9,661,033,000
+3.3%
73,440
+1.2%
0.10%
-5.8%
Q1 2021$9,355,270,000
-27.6%
72,589
-6.4%
0.10%
-29.9%
Q4 2020$12,929,952,000
+4.2%
77,527
-3.6%
0.15%
-12.5%
Q3 2020$12,413,964,000
+1.8%
80,443
-2.4%
0.17%
-7.7%
Q2 2020$12,194,652,000
+56.9%
82,452
+19.4%
0.18%
+35.8%
Q1 2020$7,773,693,000
-32.7%
69,032
-16.9%
0.13%
-10.1%
Q4 2019$11,552,385,000
+44.8%
83,039
+0.2%
0.15%
+34.2%
Q3 2019$7,979,053,000
+46.1%
82,839
-5.0%
0.11%
+19.4%
Q4 2018$5,460,574,00087,1600.09%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q4 2020
NameSharesValueWeighting ↓
RA Capital Management 11,225,357$1,001,863,11218.92%
Q Global Advisors, LLC 195,000$17,40412.55%
Sofinnova Investments, Inc. 754,032$67,297,3564.41%
Avoro Capital Advisors LLC 3,580,555$319,564,5344.34%
Finepoint Capital LP 139,772$12,474,6514.32%
Spyglass Capital Management LLC 657,853$58,713,3804.24%
Saturn V Capital Management LP 78,442$7,000,9483.88%
DAFNA Capital Management LLC 135,212$12,067,6713.30%
ARS Investment Partners, LLC 289,860$25,870,0053.02%
Ghost Tree Capital, LLC 100,000$8,925,0002.95%
View complete list of ASCENDIS PHARMA A/S shareholders